Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
PharmAbcine Receives IND Approval from the Korean MFDS for Phase I Clinical Trial of Its Novel TIE2 Agonistic Antibody in nAMD 2023-05-23 20:00
SK bioscience Presents Solution for Equitable Access of Vaccine at Regionalized Vaccine Manufacturing Collaborative of World Economic Forum 2023-05-23 20:00
BrightInsight Named 2023 Global Company of the Year by Frost & Sullivan for Enabling Better Patient Outcomes with Digital Solutions 2023-05-23 20:00
Minghui Pharmaceutical Inc. Announces First-in-Human Dose of MHB018A, a Subcutaneous Single-Domain IGF-1R Antibody in Phase 1a Healthy Volunteer Study 2023-05-23 19:00
Introducing Ceretone's Core One: The Revolutionary OTC Hearing Aid Launching on Indiegogo in May 2023-05-23 18:01
Antengene Announces Claudin 18.2 Antibody-Drug Conjugate ATG-022 Granted Orphan Drug Designations by the U.S. FDA for the Treatment of Gastric and Pancreatic Cancers 2023-05-23 17:25
OMRON Healthcare Celebrates 50 Years of Blood Pressure Monitor History 2023-05-23 14:00
OMRON Healthcare Celebrates 50 Years of Blood Pressure Monitor History 2023-05-23 14:00
Chula Medicine Found Thai Herbal Tea Comparable to Modern Medicines in Stimulating Breast Milk Production 2023-05-23 13:39
Nona Biosciences Enters into Antibody Discovery Agreement with OPKO Health's ModeX Therapeutics 2023-05-23 13:00
Acepodia Announces First Patient Dosed in Phase 1 Clinical Trial of ACE1831, an Anti-CD20 Armed Allogeneic Gamma Delta T-cell Therapy in Development to Treat Patients with Non-Hodgkin's Lymphoma 2023-05-23 00:00
HanX Biopharmaceuticals announces HX009 IND approval from FDA 2023-05-22 22:00
CSafe Providing Sustainable Thermal Protection for Vyjuvek Gene Therapy from Krystal Biotech 2023-05-22 21:23
EBR Systems' Pivotal SOLVE-CRT Trial Meets Endpoints: Excellent Interim Analysis Results Lead to Early Trial Halt for Success 2023-05-22 21:00
Proem Behavioral Health and Dr. David V. Sheehan Issue Joint Statement 2023-05-22 20:00
A random placebo-controlled clinical trial by CU Medicine shows that modulation of gut microbiome using oral microencapsulated live bacteria (SIM01) improves long COVID symptoms 2023-05-22 16:37
WuXi Biologics Receives 2023 ISPE Facility of the Year Award for Operations 2023-05-22 16:30
CORVIA MEDICAL RELEASES TWO-YEAR CLINICAL TRIAL RESULTS CONFIRMING SUSTAINED BENEFIT AND SAFETY OF ITS ATRIAL SHUNT IN HEART FAILURE PATIENTS 2023-05-22 16:02
TVM Capital Healthcare Announces Euro 10 Million Investment in DEBx Medical 2023-05-22 14:00
1 in 10[1] people and 1 in 2 diabetics[2] suffer from Peripheral Neuropathy while 80% of patients remain undiagnosed[3] 2023-05-22 11:45
1 195 196 197 198 199 970